Queen Elizabeth University Hospital | ClinicalTrials HQ

5 results · Page 1 of 1

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Open-Label Extension (OLE) Study to Assess Safety, Efficacy, and Tolerability of Lorundrostat in Subjects With Hypertension	cardiovascular disorder, hypertensive disorder, vascular disorder	Active, not recruiting	Phase 3	2026-09-29		NCT05968430
Collection of Blood Samples for New Diagnostic Devices 2	Embolism and Thrombosis, Infections, Inflammation, Pathologic Processes, Pathological Conditions, Signs and Symptoms, cardiovascular disorder, vascular disorder	Recruiting	Not stated	2026-08-27		NCT05568966
Rewiring the Brain-Immune Axis for Chronic Pain Using Transcranial Magnetic Stimulation in Psoriatic Arthritis	Skin Diseases, Papulosquamous, Skin and Connective Tissue Diseases, Spondylarthritis, Spondylarthropathies, arthritic joint disease, arthropathy, bone disorder, musculoskeletal system disorder, psoriasis, psoriatic arthritis, skin disorder, spondylitis, vertebral column disorder	Not yet recruiting	Not applicable	2026-02-11		NCT07403890
Targeted Assessment in High-Risk paTients With dIAbetes to ideNtify Undiagnosed Heart Failure	Nutritional and Metabolic Diseases, autoimmune disease, cardiovascular disorder, diabetes mellitus, endocrine system disorder, glucose metabolism disease, heart disorder, heart failure, immune system disorder, metabolic disease, type 1 diabetes mellitus, type 2 diabetes mellitus	Active, not recruiting	Not applicable	2026-01-14		NCT05705869
Evaluating the Role of IL-17 as an Orchestrator of Peripheral-central Cross Talk in Depressive Symptoms	Skin Diseases, Papulosquamous, Skin and Connective Tissue Diseases, Spondylarthritis, Spondylarthropathies, arthritic joint disease, arthropathy, bone disorder, depressive disorder, musculoskeletal system disorder, psoriasis, psoriatic arthritis, skin disorder, spondylitis, vertebral column disorder	Recruiting	Not stated	2025-06-19		NCT06786936